Population-weighted estimates showed that fewer than 18% of eligible patients actually got a low-dose CT scan for lung cancer ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

Amit Gupta, MD, discussed a new collaboration between University Hospitals Cleveland Medical Center and Qure.ai that aims to ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

A study found a "significant" link between the frequency of chest X-ray referrals and improved survival rates for lung cancer ...

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer ...

On Wednesday morning, April 2, UH announced its partnership with Qure.AI, a global health tech startup, to use its AI ...

Every year, 1.8 million people lose their lives to lung cancer, making it one of the deadliest diseases and one of the leading causes of cancer-related deaths worldwide. A major reason for the high ...

An exploratory analysis shows a reduction in extrathoracic metastases and prolonged time to progression or death due to any metastases with durvalumab vs placebo.

Annual lung cancer screening, or LCS, detects cancer at a higher rate and at earlier stages, findings suggest.According to Roger Y. Kim, MD, MSCE, DAABIP, ATSF, an assistant professor of medicine at ...